October 7, 2022

Tofacitinib Shows Promise in Scleroderma Patients, Researchers Are Optimistic for Next Phase of Study

Dinesh Khanna, MBBS, MSc and colleagues find that tofacitinib was well tolerated among patients with early systemic sclerosis in a phase I/II study.